BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24522888)

  • 1. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
    Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
    Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
    BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of annexin II expression in human non-small cell lung cancer.
    Jia JW; Li KL; Wu JX; Guo SL
    Tumour Biol; 2013 Jun; 34(3):1767-71. PubMed ID: 23494179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer.
    Li Z; Yu CP; Zhong Y; Liu TJ; Huang QD; Zhao XH; Huang H; Tu H; Jiang S; Zhang Y; Liu JH; Song LB
    Ann Oncol; 2012 Mar; 23(3):638-646. PubMed ID: 21700735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
    Li H; Zhou RJ; Zhang GQ; Xu JP
    Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.
    Qin H; Ni Y; Tong J; Zhao J; Zhou X; Cai W; Liang J; Yao X
    Med Oncol; 2014 Aug; 31(8):142. PubMed ID: 25048725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of SAM68 in the progression and prognosis for bladder cancer.
    Zhang Z; Yu C; Li Y; Jiang L; Zhou F
    BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.